Skip to main content
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1983 Nov 12;287(6403):1405–1407. doi: 10.1136/bmj.287.6403.1405

Calcium antagonists in hypertension: relation to abnormal sodium transport.

A M Heagerty, R F Bing, H Thurston, J D Swales
PMCID: PMC1549661  PMID: 6416434

Abstract

Leucocyte sodium efflux rate constants and intracellular electrolyte contents were estimated in 13 patients with untreated essential hypertension. There was no correlation between intracellular sodium or potassium content or efflux rate constant and blood pressure. The patients were then treated with oral nifedipine and blood pressure controlled. Sodium efflux rate constants and electrolyte contents were estimated one and three months after the start of treatment. There was a significant fall in blood pressure, but mean sodium efflux rate constant and intracellular sodium content were unchanged. There was no correlation between the fall in blood pressure, initial sodium efflux, or intracellular sodium content. These data do not support the hypothesis that the sodium pump and intracellular sodium content have a direct role in generating raised blood pressure, or that treatment of hypertension with calcium antagonists corrects a fundamental alteration of calcium-sodium exchange across the cell membrane.

Full text

PDF
1405

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blaustein M. P. Sodium ions, calcium ions, blood pressure regulation, and hypertension: a reassessment and a hypothesis. Am J Physiol. 1977 May;232(5):C165–C173. doi: 10.1152/ajpcell.1977.232.5.C165. [DOI] [PubMed] [Google Scholar]
  2. Braunwald E. Mechanism of action of calcium-channel-blocking agents. N Engl J Med. 1982 Dec 23;307(26):1618–1627. doi: 10.1056/NEJM198212233072605. [DOI] [PubMed] [Google Scholar]
  3. Edmondson R. P., Thomas R. D., Hilton P. J., Patrick J., Jones N. F. Abnormal leucocyte composition and sodium transport in essential hypertension. Lancet. 1975 May 3;1(7914):1003–1005. doi: 10.1016/s0140-6736(75)91947-9. [DOI] [PubMed] [Google Scholar]
  4. Heagerty A. M., Milner M., Bing R. F., Thurston H., Swales J. D. Leucocyte membrane sodium transport in normotensive populations: dissociation of abnormalities of sodium efflux from raised blood-pressure. Lancet. 1982 Oct 23;2(8304):894–896. doi: 10.1016/s0140-6736(82)90865-0. [DOI] [PubMed] [Google Scholar]
  5. Motulsky H. J., Snavely M. D., Hughes R. J., Insel P. A. Interaction of verapamil and other calcium channel blockers with alpha 1- and alpha 2-adrenergic receptors. Circ Res. 1983 Feb;52(2):226–231. doi: 10.1161/01.res.52.2.226. [DOI] [PubMed] [Google Scholar]
  6. Robinson B. F., Dobbs R. J., Bayley S. Response of forearm resistance vessels to verapamil and sodium nitroprusside in normotensive and hypertensive men: evidence for a functional abnormality of vascular smooth muscle in primary hypertension. Clin Sci (Lond) 1982 Jul;63(1):33–42. doi: 10.1042/cs0630033. [DOI] [PubMed] [Google Scholar]
  7. Rothstein A. Membrane phenomena. Annu Rev Physiol. 1968;30:15–72. doi: 10.1146/annurev.ph.30.030168.000311. [DOI] [PubMed] [Google Scholar]
  8. Swales J. D. Ion transport in hypertension. Biosci Rep. 1982 Dec;2(12):967–990. doi: 10.1007/BF01122165. [DOI] [PubMed] [Google Scholar]
  9. de Wardener H. E., MacGregor G. A. The natriuretic hormone and essential hypertension. Lancet. 1982 Jun 26;1(8287):1450–1454. doi: 10.1016/s0140-6736(82)92462-x. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES